Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCharacter Regulatory News (CCT)

Share Price Information for Character (CCT)

Share Price is delayed by 15 minutes
Get Live Data
290.00    0.00 (0.00%)
Bid:
280.00
Ask:
300.00
Spread: 20.00 (7.143%)
Market Cap: £50.47m
CCT Live PriceLast checked at - London Stock Exchange

Intraday Character Share Chart

New Share Buyback Programme

2 Feb 2026 15:07

RNS Number : 3746R
Character Group PLC (The)
02 February 2026
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Monday, 2 February 2026

The Character Group plc

("Character," the "Company" or the "Group")

New Share Buyback Programme

Character (AIM:CCT) today announces the launch of a new share buyback programme (the "2026 Share Buyback Programme"), following the completion of its previous share buyback programme, pursuant to which approximately £3.0 million worth of ordinary shares of 5 pence each in the Company ("Ordinary Shares") were purchased on behalf of the Company between 29 October 2024 and 15 January 2026.

The Board continues to believe that the Company's share price significantly undervalues the Group. Therefore, to further enhance shareholder returns and to reduce the Company's share capital, the Board has today approved the 2026 Share Buyback Programme to repurchase Ordinary Shares for up to a maximum aggregate consideration of £3.0 million, which will be funded out of the Group's existing cash resources.

The 2026 Share Buyback Programme will be carried out pursuant to the approvals granted by shareholders at the Annual General Meeting held on 16 January 2026 (the "General Authority") and will commence on the date of this announcement and continue until either the maximum pecuniary amount has been purchased under the 2026 Share Buyback Programme or, if earlier, 14 January 2027. The 2026 Share Buyback Programme will also automatically terminate upon the Company giving notice that any person (or group of persons known to be acting in concert) has become interested in Ordinary Shares carrying 29% or more of the voting rights in the Company.

The Company has entered into an irrevocable commitment with Panmure Liberum Limited ("Panmure Liberum") to conduct the 2026 Share Buyback Programme and repurchase Ordinary Shares on the Company's behalf and to make trading decisions under the programme in accordance with certain pre-set parameters independently of the Company.

Share purchases under the 2026 Share Buyback Programme will take place in open market transactions and may be made from time to time depending on market conditions, share price, trading volume and other terms. The maximum price paid per Ordinary Share will be no more than: (i) the higher of the price of the last independent trade and the highest current independent purchase bid for Ordinary Shares on the trading venue where the purchase is carried out; and (ii) 105 per cent of the average closing middle market quotations of an Ordinary Share for the five business days immediately preceding the day on which such Ordinary Shares are purchased. Under the 2026 Share Buyback Programme, the shares repurchased by the Company will be cancelled.

 

There is no guarantee that the 2026 Share Buyback Programme will be implemented in full or that any purchases will be made. The Company reserves the right to bring a halt to the 2026 Share Buyback Programme under circumstances that it deems to be appropriate and in accordance with relevant law and regulation.

The 2026 Share Buyback Programme will be conducted within the pricing parameters of the Market Abuse Regulation 596/2014/EU and the delegated regulations made pursuant to it (the "Regulations"). However, given the limited liquidity in the issued Ordinary Shares, the Company has agreed that, on any trading day, a buy-back of Ordinary Shares under the 2026 Share Buyback Programme may exceed 25% but not more than 50% of the average daily trading volume in the Ordinary Shares in the 20 trading days preceding the date on which a buy-back of Ordinary Shares is carried out. Accordingly, the Company may not benefit from the exemption contained in the Regulations.

The Company will make further regulatory announcements in respect of repurchases of Ordinary Shares as required by UK MAR and the AIM Rules.

The Company confirms that it currently has no other unpublished price sensitive information at the time of this announcement.

 

The Character Group plc

FTSE sector: leisure goods:

FTSE AIM All-share: symbol: CCT

Market cap: £42m

Email:  info@charactergroup.plc.uk

Group website: www.thecharacter.com

Product ranges can also be viewed at www.character-online.co.uk

CHARACTER GROUP PLC CCT Stock | London Stock Exchange

 

 

Enquiries to:

The Character Group plc

Jon Diver, Joint Managing Director

Kiran Shah, Joint Managing Director

Hamun Shah, Group Finance Director

Office: +44 (0) 208 329 3377

Mobile: +44 (0) 7831 802219 (JD)

Mobile: +44 (0) 7956 278522 (KS)

Mobile: +44 (0) 7989 517315 (HS)

 

Panmure Liberum (Nominated Adviser and Joint Broker)

Atholl Tweedie, Investment Banking

Rupert Dearden, Corporate Broking

Tel: +44 (0) 20 7886 2500

Allenby Capital Limited (Joint Broker)

Nick Athanas, Corporate Finance

Amrit Nahal / Tony Quirke, Sales & Corporate Broking

Tel: +44 (0) 20 3328 5656

 

TooleyStreet Communications Limited (Investor and media relations)

Fiona Tooley

Tel: +44 (0) 7785 703523

Email: fiona@tooleystreet.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRBUGDDLGGDGLD
Date   Source Headline
3rd May 20177:00 amRNSTotal Voting Rights
27th Apr 20174:33 pmRNSTransaction in Own Shares & Directors Shareholding
27th Apr 20177:00 amRNSHalf-Yearly Financial Report period ended 28.2.17
14th Mar 201710:26 amRNSDirector/PDMR Shareholding
23rd Jan 20173:26 pmRNSDirector/PDMR Shareholding
20th Jan 201712:46 pmRNSResult of AGM
20th Jan 20177:00 amRNSTrading Update
23rd Dec 20166:13 pmRNS2016 Annual Financial Report & Notice of AGM
12th Dec 20165:31 pmRNSDirector/PDMR Shareholding
1st Dec 20167:00 amRNSPreliminary Results - year ended 31 August 2016
30th Sep 20162:38 pmRNSTotal Voting Rights
22nd Sep 20167:00 amRNSTransaction in Own Shares
21st Sep 20168:39 amRNSDirector/PDMR Shareholding
20th Sep 20162:50 pmRNSShare buy-backs
14th Sep 20167:00 amRNSTrading Update
11th Jul 201611:50 amRNSDirector/PDMR Shareholding
23rd Jun 20167:00 amRNSTransaction in Own Shares
21st Jun 20166:25 pmRNSTransaction in Own Shares
8th Jun 201612:49 pmRNSBlock listing Interim Review
31st May 20163:28 pmRNSTotal Voting Rights
16th May 20163:27 pmRNSHolding(s) in Company
27th Apr 20167:00 amRNSHalf Yearly Financial Report period ended 29.2.16
6th Apr 201612:00 pmRNSNotice of Results
9th Mar 201612:13 pmRNSHolding(s) in Company
22nd Jan 20161:08 pmRNSResult of AGM
22nd Jan 20167:01 amRNSAppointment of Directors
22nd Jan 20167:00 amRNSTrading Update
31st Dec 201512:01 pmRNSTotal Voting Rights
31st Dec 20158:27 amRNSTransaction in Own Shares
30th Dec 20159:41 amRNSTransaction in Own Shares
24th Dec 20157:24 amRNSDirector/PDMR Shareholding
21st Dec 20157:00 amRNSTransaction in Own Shares
18th Dec 20156:28 pmRNSAnnual Financial Report
7th Dec 20155:14 pmRNSDirector/PDMR Shareholding
1st Dec 20157:00 amRNSPreliminary results - year ended 31 August 2015
24th Nov 20157:00 amRNSNotice of Results
20th Nov 20154:54 pmRNSHolding(s) in Company
30th Sep 201510:51 amRNSTotal Voting Rights
28th Sep 20152:42 pmRNSBlocklisting Interim Review
18th Sep 20155:38 pmRNSHolding(s) in Company
17th Sep 20155:15 pmRNSDirector's share dealing
8th Sep 201511:49 amRNSTrading update & Change of adviser
1st Sep 201510:30 amRNSTotal Voting Rights
19th Aug 20155:27 pmRNSDirector/PDMR Shareholding
6th Aug 20155:16 pmRNSDirector/PDMR Shareholding
15th Jul 20154:25 pmRNSDirector obituary - Lord Birdwood
30th Jun 201511:46 amRNSTotal Voting Rights
5th Jun 201511:34 amRNSHolding(s) in Company
4th Jun 20156:03 pmRNSDirector/PDMR Shareholding
2nd Jun 20155:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.